Mental Health Services Research

, Volume 7, Issue 4, pp 225–228

Relationship Between Preventative Physical Health Care and Mental Health in Individuals with Schizophrenia: A Survey of Caregivers

  • Joan A. Mackell
  • David J. Harrison
  • Diana D. McDonnell
Article

Abstract

The relationship between preventative physical health care and mental health in individuals with schizophrenia was assessed retrospectively by questionnaires completed by 504 caregivers. Psychiatric symptom severity and quality-of-life data on 332 respondents were evaluable. Suboptimal preventative physical health care was defined as absence of ≥2 examinations within a specified time: physical and dental within 12 months, eye within 24 months. Findings revealed similar use of mental health care services for all individuals, but those in the suboptimal physical health care group (n = 93 [28%]) had a lower quality of life (p < .011), more negative symptoms (p < .009), less paid employment (p < .001), and more alcohol/drug abuse (p = .02). These findings suggest that mental health care providers should play a more active role in monitoring the basic physical health care of patients with schizophrenia.

Keywords

schizophrenia caregivers physical health care mental health care quality of life 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison, D. B., Mentore, J. L., Moonseong, H., Chandler, L. P., Cappelleri, J. C., Infante, M. C., et al. (1999). Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry, 156, 1686–1696.PubMedGoogle Scholar
  2. Brown, S., Inskip, H., & Barraclough, B. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212–217.CrossRefPubMedGoogle Scholar
  3. Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine, 29, 697–701.PubMedGoogle Scholar
  4. Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., & Lehman, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease, 187, 496–502.CrossRefPubMedGoogle Scholar
  5. Goldman, L. S. (1999). Medical illness in patients with schizophrenia. Journal of Clinical Psychiatry, 60(Suppl. 1), 10–15.PubMedGoogle Scholar
  6. Hedenmalm, K., Hagg, S., Stahl, M., Mortimer, O., Spigset, O. (2002). Glucose intolerance with atypical antipsychotics. Drug Safety, 25, 1107–1116.PubMedGoogle Scholar
  7. Holmberg, S. K., & Kane, C. (1999). Health and self-care practices of persons with schizophrenia. Psychiatric Services, 50, 827–829.PubMedGoogle Scholar
  8. McCreadie, R. J., MacDonald, E., Blacklock, C., Tilak-Singh, D., Wiles, D., Halliday, J., et al. (1998). Dietary intake of schizophrenic patients in Nithsdale, Scotland, case–control study. British Medical Journal, 317, 284–785.Google Scholar
  9. Neumann, P. J., Araki, S. S., & Gutterman, E. M. (2000). The use of proxy respondents in studies of older adults: Lessons, challenges, and opportunities. Journal of the American Geriatric Society, 48, 1646–1654.Google Scholar
  10. Russell, J. M., & Mackell, J. A. (2001). Bodyweight gain associated with atypical antipsychotics. CNS Drugs, 15, 537–551.PubMedGoogle Scholar
  11. Vieweg, V., Levenson, J., & Pandurangi, A. (1995). Medical disorders in the schizophrenic patient. International Journal of Psychiatry in Medicine, 25, 137–172.PubMedGoogle Scholar
  12. Weiden, P. J., Daniel, D. G., Simpson, G., & Romano, S. J. (2003). Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone. Journal of Clinical Psychopharmacology, 23, 595–600.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Joan A. Mackell
    • 1
    • 3
  • David J. Harrison
    • 1
    • 2
  • Diana D. McDonnell
    • 2
  1. 1.Pfizer Inc.New York
  2. 2.Consumer Health SciencesPrinceton
  3. 3.Outcomes Research, Pfizer Inc.New York

Personalised recommendations